Take a peek inside the brain with prize-winning artwork inspired by research at The Ottawa Hospital
July 6, 2023 - Patients, visitors and staff at TOH’s General Campus can now experience what it might be like to float through the human brain, thanks to a unique collaboration between local artist Svetlana Swinimer and neuroscientist Dr. Michael Schlossmacher. |
Discovery reveals how Parkinson’s-linked gene protects the brain
April 5, 2023 - For more than 20 years, researchers have known that young-onset Parkinson’s disease is often caused by mutations in the parkin gene, but the exact function of this gene has been hotly debated. |
Predicting Parkinson’s: mathematical model could help with earlier diagnosis and treatment
September 23, 2022 - An innovative mathematical model developed by researchers at The Ottawa Hospital could one day help with the prevention and early treatment of Parkinson’s disease. |
The Ottawa Hospital’s push to demystify Parkinson’s disease
April 29, 2022 - Parkinson’s is the second most common neurodegenerative disease after Alzheimer’s, affecting at least 100,000 Canadians. Researchers at The Ottawa Hospital are on the global stage seeking answers for patients desperately waiting for a breakthrough. |
Meet Dr. Michael Schlossmacher
April 29, 2022 - Growing up in Austria, Dr. Michael Schlossmacher couldn’t have foreseen his future as a physician-scientist conducting groundbreaking Parkinson’s research at The Ottawa Hospital. |
Does Parkinson’s start in the nose? International team awarded US$9 million ASAP grant to find out
October 26, 2021 - More than 80 percent of people with Parkinson’s disease suffer from a reduced sense of smell, something that often occurs years before the onset of typical movement-related symptoms. Now, thanks to a US$9 million grant from the Aligning Science ... |
Experts on call: Parkinson’s care and research
April 22, 2021 - Topics of discussion will include recently approved Parkinson’s drugs, Duodopa pump treatment and progress in understanding early-onset Parkinson’s. |
Parkinson’s discovery points to possible future treatment approaches
April 6, 2021 - More than 20 years after the discovery of the parkin gene linked to young-onset Parkinson’s disease, researchers at The Ottawa Hospital and the University of Ottawa may have finally figured out how this mysterious gene protects the brain. |
Researchers at The Ottawa Hospital awarded 17 CIHR grants worth $7.5 million
March 10, 2021 - Researchers at The Ottawa Hospital are playing a lead role in 17 new projects funded by the Canadian Institutes of Health Research (CIHR). |
Decoding the mystery of Parkinson’s disease
July 10, 2020 - For more than 200 years, no one has been able to solve the Parkinson puzzle. While the exact cause of the disease remains a mystery, dedicated researchers at The Ottawa Hospital are gaining ground—determined to solve the puzzle. |
New Frontiers in Research Fund supports trailblazing research on autism, Alzheimer’s, Parkinson’s
June 3, 2020 - Researchers from The Ottawa Hospital are involved in four new projects funded through the Exploration stream of Canada’s New Frontiers in Research Fund. The fund is designed to support high-risk, high-reward and interdisciplinary research. |
Unravelling the mystery of how one gene contributes to Parkinson’s, Crohn’s and leprosy
September 25, 2019 - Researchers have struggled for years to understand how mutations in one gene, called LRRK2, can increase the risk of three very different diseases: Parkinson’s (a brain disease), Crohn’s (a gut disease) and leprosy (a peripheral nervous system ... |
Researchers honoured for outstanding work in Parkinson’s, critical care and surgery
April 11, 2019 - A number of outstanding researchers and research teams were recognized at The Ottawa Hospital’s Excellence Awards Ceremony on April 11. They include the Parkinson Research Consortium, the Operating Room Black Box® Research Program and ICU ... |
Brain Health Awareness Week: October 15-19
October 10, 2018 - Researchers, clinicians, patients and members of the general public are invited to take part in Brain Health Awareness Week from October 5-19, hosted by the University of Ottawa Brain and Mind Research Institute, in collaboration with The Ottawa ... |
Award-winning scientist challenges medical dogma in quest to prevent, treat neurodegenerative disease
October 25, 2017 - Dr. Michael Schlossmacher grew up in Austria, trained at Harvard and now leads The Ottawa Hospital’s neuroscience research program. His research helped establish a key concept in Alzheimer’s disease and led to a clinical trial of an experimental ther |
Parkinson’s-related protein also protects against infections
June 14, 2017 - Scientists have known for more than a century that Parkinson’s disease is associated with strange clumps of protein in the brain. Twenty years ago, researchers found that these clumps are mainly made of a protein called alpha-synuclein, but the nor |
Grant helps researchers better study important young-onset Parkinson’s protein
January 25, 2017 - Dr. Michael Schlossmacher and BioLegend Inc.’s Dr. Peggy Taylor were awarded $200,000 USD by The Michael J. Fox Foundation for Parkinson’s Research to create research tools that can identify various forms of a specific brain protein that is ... |
Weston grants to accelerate development of new therapies for Parkinson disease and related dementias
November 26, 2014 - Drs. Michael Schlossmacher and Julianna Tomlinson and their colleagues have been awarded $300,000 from the Weston Brain Institute for two research projects aimed at developing new therapies for Parkinson disease and dementia with Lewy bodies. These p |
